Dr. Stacey Clardy talks with Dr. Sandra Vukusic about the disparities in treatment for female patients with multiple sclerosis, particularly focusing on how pregnancy influences treatment decisions and the overall lower exposure to disease-modifying…
Read MoreDr. Justin Abbatemarco talks with Dr. Daniel Ontaneda about the 2024 revisions of the McDonald criteria for diagnosing multiple sclerosis. Read the related article in . Disclosures can be found at .
Read MoreDr. Justin Abbatemarco talks with Dr. Jiwon Oh about Bruton Tyrosine Kinase (BTK) Inhibitors and the recent data on tolebrutinib in multiple sclerosis. Read the related article on Tolebrutinib versus Teriflunomide in . Read the related article on…
Read MoreDr. Alison Christy talks with Dr. Wallace J. Brownlee about whether dissemination in time (DIT) is necessary to make a diagnosis of MS in patients who fulfill a high number of dissemination in space (DIS) criteria. Read the related article in . …
Read MoreThe August 2024 recall showcases four previously posted episodes on the topic of Multiple Sclerosis. In the first episode, Dr. Géraldine Androdias discusses the impact of immune checkpoint inhibitors on multiple sclerosis. The episode leads into Dr….
Read MoreAs part of our «Physician as Patient» series, Dr. Andy Southerland talks with Dr. Eric Seachrist about his experience with multiple sclerosis. This podcast is sponsored by argenx. Visit for more information. Disclosures can be found at .
Read MoreDr. Justin Abbatemarco talks with Dr. Bob Fox about the relationship between serum neurofilament light chain (sNfL) levels and radiologic multiple sclerosis disease activity. Read the related article in . Disclosures can be found at .
Read MoreDr. Justin Abbatemarco talks with Dr. Ellen Iacobaeus about patient characteristics, disease-modifying therapy, and disability progression in Swedish patients with late-onset MS and adult-onset MS over 2 decades. Read the related article…
Read MoreDr. Justin Abbatemarco talks with Dr. Géraldine Androdias about the impact of immune checkpoint inhibitors on the course of multiple sclerosis. Read the related article in . Disclosures can be found at Neurology.org.
Read MoreBenefits of AI in health care: How is AI used by doctors? What is augmented intelligence? How are LLMs used in medicine? What is ambient AI for medical documentation?
Our guest is Vincent Liu, MD, MS, chief data officer, at The Permanente Medical Group. American Medical Association CXO Todd Unger hosts.
🏥 Learn more about the AMA Health System Program here: https://bit.ly/AMA_HealthSystemProgram
🧠 Wondering what is the difference between augmented intelligence and artificial intelligence in health care? Check out: https://www.ama-assn.org/practice-management/digital/augmented-intelligence-medicine
🩺 The AMA is your powerful ally in patient care. Join now: https://bit.ly/AMAJoinRenew
Read More
Comentarios recientes